Vault-13

Bellevue Group AG

ZURICH, V8 · CIK 1674546 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Other 13F filers in this group: Bellevue Asset Management AG files a notice

$4.8bn reported value +13.1% vs Q1 2026
148positions
42.9%in top 10
17 new 41 added 66 reduced 24 sold out vs Q1 2026

This report includes the holdings of 2 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AMGEN INC COM AMGN AMGN 851,550 $308.4m6.49% 6.49% AddedShares held: Q3 2025 15.0k, Q4 2025 18.5k, Q1 2026 295.4k, Q2 2026 851.5k +556.2k +556,192 188.3%
2 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 578,634 $287.4m6.05% 6.05% ReducedShares held: Q3 2025 505.8k, Q4 2025 681.1k, Q1 2026 681.9k, Q2 2026 578.6k -103.3k -103,274 -15.1%
3 ARGENX SE SPONSORED ADR ARGX ARGX 301,000 $279.3m5.88% 5.88% ReducedShares held: Q3 2025 546.3k, Q4 2025 461.9k, Q1 2026 313.0k, Q2 2026 301.0k -12.0k -12,000 -3.8%
4 GILEAD SCIENCES INC COM GILD GILD 2,158,772 $272.7m5.74% 5.74% AddedShares held: Q3 2025 49.9k, Q4 2025 52.8k, Q1 2026 1.2m, Q2 2026 2.2m +988.9k +988,893 84.5%
5 REVOLUTION MEDICINES INC COM RVMD RVMD 1,048,014 $196.3m4.13% 4.13% ReducedShares held: Q3 2025 5.6m, Q4 2025 5.0m, Q1 2026 1.5m, Q2 2026 1.0m -496.4k -496,442 -32.1%
6 ORUKA THERAPEUTICS INC COM ORKA ORKA 1,657,190 $157.7m3.32% 3.32% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 507.0k, Q2 2026 1.7m +1.2m +1,150,182 226.9%
7 INSMED INC COM PAR $.01 INSM INSM 1,393,418 $148.6m3.13% 3.13% AddedShares held: Q3 2025 20.3k, Q4 2025 13.9k, Q1 2026 10.0k, Q2 2026 1.4m +1.4m +1,383,384 13787.0%
8 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 2,449,547 $134.7m2.83% 2.83% ReducedShares held: Q3 2025 3.2m, Q4 2025 4.1m, Q1 2026 3.6m, Q2 2026 2.4m -1.1m -1,135,026 -31.7%
9 NUVALENT INC COM COM 1,053,268 $130.1m2.74% 2.74% UnchangedShares held: Q3 2025 0, Q4 2025 1.0m, Q1 2026 1.1m, Q2 2026 1.1m
10 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 6,731,909 $123.7m2.60% 2.60% AddedShares held: Q3 2025 0, Q4 2025 4.4m, Q1 2026 6.7m, Q2 2026 6.7m +5.8k +5,765 0.1%
11 RELAY THERAPEUTICS INC COM RLAY RLAY 6,185,970 $115.7m2.44% 2.44% ReducedShares held: Q3 2025 8.3m, Q4 2025 8.3m, Q1 2026 7.8m, Q2 2026 6.2m -1.6m -1,609,272 -20.6%
12 VAXCYTE INC COM PCVX PCVX 1,971,935 $114.6m2.41% 2.41% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 2.0m +781.2k +781,238 65.6%
13 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 188,515 $102.1m2.15% 2.15% AddedShares held: Q3 2025 2.6k, Q4 2025 3.9k, Q1 2026 2.1k, Q2 2026 188.5k +186.4k +186,438 8976.3%
14 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 254,809 $101.3m2.13% 2.13% ReducedShares held: Q3 2025 348.6k, Q4 2025 322.0k, Q1 2026 286.7k, Q2 2026 254.8k -31.8k -31,845 -11.1%
15 REGENERON PHARMACEUTICALS COM REGN REGN 157,291 $98.1m2.06% 2.06% ReducedShares held: Q3 2025 15.1k, Q4 2025 13.9k, Q1 2026 278.7k, Q2 2026 157.3k -121.4k -121,383 -43.6%
16 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 2,620,000 $98.0m2.06% 2.06% ReducedShares held: Q3 2025 0, Q4 2025 4.0k, Q1 2026 3.3m, Q2 2026 2.6m -660.0k -660,000 -20.1%
17 BRIDGEBIO PHARMA INC COM BBIO BBIO 1,189,506 $88.6m1.86% 1.86% AddedShares held: Q3 2025 20.4k, Q4 2025 24.1k, Q1 2026 25.4k, Q2 2026 1.2m +1.2m +1,164,129 4587.3%
18 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 2,788,245 $88.5m1.86% 1.86% ReducedShares held: Q3 2025 2.8m, Q4 2025 2.8m, Q1 2026 2.8m, Q2 2026 2.8m -8.6k -8,558 -0.3%
19 ABBOTT LABS COM ABT ABT 947,115 $85.9m1.81% 1.81% ReducedShares held: Q3 2025 1.5m, Q4 2025 1.3m, Q1 2026 1.2m, Q2 2026 947.1k -204.5k -204,520 -17.8%
20 STRYKER CORPORATION COM SYK SYK 268,461 $84.5m1.78% 1.78% AddedShares held: Q3 2025 451.1k, Q4 2025 360.6k, Q1 2026 217.2k, Q2 2026 268.5k +51.2k +51,224 23.6%
21 MEDTRONIC PLC SHS MDT MDT 994,233 $77.8m1.64% 1.64% AddedShares held: Q3 2025 759.9k, Q4 2025 766.6k, Q1 2026 957.3k, Q2 2026 994.2k +36.9k +36,904 3.9%
22 IONIS PHARMACEUTICALS INC COM IONS IONS 972,258 $77.1m1.62% 1.62% ReducedShares held: Q3 2025 6.2m, Q4 2025 4.8m, Q1 2026 1.8m, Q2 2026 972.3k -846.4k -846,407 -46.5%
23 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 1,490,000 $75.6m1.59% 1.59% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.3m, Q2 2026 1.5m -830.9k -830,867 -35.8%
24 VERA THERAPEUTICS INC CL A VERA VERA 1,710,808 $73.4m1.54% 1.54% AddedShares held: Q3 2025 0, Q4 2025 1.7m, Q1 2026 1.7m, Q2 2026 1.7m +37 +37 0.0%
25 JADE BIOSCIENCES INC COM NEW JBIO JBIO 3,057,996 $67.9m1.43% 1.43% ReducedShares held: Q3 2025 0, Q4 2025 3.3m, Q1 2026 3.5m, Q2 2026 3.1m -443.5k -443,506 -12.7%
26 EDWARDS LIFESCIENCES CORP COM EW EW 739,234 $66.9m1.41% 1.41% ReducedShares held: Q3 2025 896.6k, Q4 2025 1.0m, Q1 2026 839.5k, Q2 2026 739.2k -100.2k -100,217 -11.9%
27 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 1,982,775 $66.2m1.39% 1.39% ReducedShares held: Q3 2025 0, Q4 2025 2.6k, Q1 2026 2.4m, Q2 2026 2.0m -397.2k -397,225 -16.7%
28 UNITEDHEALTH GROUP INC COM UNH UNH 149,127 $62.0m1.30% 1.30% AddedShares held: Q3 2025 170.1k, Q4 2025 175.2k, Q1 2026 148.2k, Q2 2026 149.1k +924 +924 0.6%
29 DEXCOM INC COM DXCM DXCM 822,489 $55.4m1.17% 1.17% AddedShares held: Q3 2025 786.1k, Q4 2025 847.4k, Q1 2026 788.8k, Q2 2026 822.5k +33.7k +33,723 4.3%
30 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 1,200,000 $44.7m0.94% 0.94% UnchangedShares held: Q3 2025 3.6m, Q4 2025 3.6m, Q1 2026 1.2m, Q2 2026 1.2m
31 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 1,350,000 $44.4m0.94% 0.94% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.4m
32 DAMORA THERAPEUTICS INC COM NEW COM NEW 1,618,846 $42.1m0.89% 0.89% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.3m, Q2 2026 1.6m -679.2k -679,154 -29.6%
33 DISC MEDICINE INC COM IRON IRON 560,000 $41.0m0.86% 0.86% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 459.3k, Q2 2026 560.0k +100.7k +100,686 21.9%
34 THERMO FISHER SCIENTIFIC INC COM TMO TMO 79,816 $40.0m0.84% 0.84% AddedShares held: Q3 2025 106.2k, Q4 2025 65.1k, Q1 2026 64.4k, Q2 2026 79.8k +15.4k +15,404 23.9%
35 BOSTON SCIENTIFIC CORP COM BSX BSX 887,650 $37.9m0.80% 0.80% ReducedShares held: Q3 2025 1.7m, Q4 2025 1.6m, Q1 2026 1.5m, Q2 2026 887.6k -579.2k -579,244 -39.5%
36 ELI LILLY & CO COM LLY LLY 29,882 $35.8m0.75% 0.75% ReducedShares held: Q3 2025 40.5k, Q4 2025 34.0k, Q1 2026 33.9k, Q2 2026 29.9k -4.0k -4,050 -11.9%
37 CG ONCOLOGY INC COM CGON CGON 493,596 $35.1m0.74% 0.74% NewShares held: Q3 2025 0, Q4 2025 3.1k, Q1 2026 0, Q2 2026 493.6k
38 IDEXX LABS INC COM IDXX IDXX 61,780 $32.5m0.68% 0.68% ReducedShares held: Q3 2025 76.6k, Q4 2025 94.5k, Q1 2026 89.1k, Q2 2026 61.8k -27.4k -27,351 -30.7%
39 RESMED INC COM RMD RMD 148,195 $28.9m0.61% 0.61% ReducedShares held: Q3 2025 164.8k, Q4 2025 161.2k, Q1 2026 159.3k, Q2 2026 148.2k -11.2k -11,151 -7.0%
40 KRYSTAL BIOTECH INC COM KRYS KRYS 77,530 $28.8m0.61% 0.61% ReducedShares held: Q3 2025 1.3k, Q4 2025 410.3k, Q1 2026 481.8k, Q2 2026 77.5k -404.3k -404,255 -83.9%
41 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 1,190,000 $28.8m0.61% 0.61% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.2m -60.0k -60,000 -4.8%
42 DANAHER CORPORATION COM DHR DHR 143,844 $27.4m0.58% 0.58% ReducedShares held: Q3 2025 163.9k, Q4 2025 194.6k, Q1 2026 202.2k, Q2 2026 143.8k -58.3k -58,320 -28.9%
43 JOHNSON & JOHNSON COM JNJ JNJ 103,280 $26.2m0.55% 0.55% ReducedShares held: Q3 2025 74.8k, Q4 2025 126.8k, Q1 2026 119.1k, Q2 2026 103.3k -15.8k -15,822 -13.3%
44 SEAPORT THERAPEUTICS INC COMMON STOCK SPTX SPTX 1,100,000 $23.9m0.50% 0.50% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
45 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 155,000 $23.7m0.50% 0.50% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 155.0k
46 ALIGN TECHNOLOGY INC COM ALGN ALGN 139,680 $23.6m0.50% 0.50% UnchangedShares held: Q3 2025 144.7k, Q4 2025 141.5k, Q1 2026 139.7k, Q2 2026 139.7k
47 ANNEXON INC COM ANNX ANNX 4,100,016 $23.4m0.49% 0.49% ReducedShares held: Q3 2025 5.2m, Q4 2025 5.2m, Q1 2026 5.2m, Q2 2026 4.1m -1.1m -1,057,274 -20.5%
48 HUMANA INC COM HUM HUM 58,398 $23.2m0.49% 0.49% ReducedShares held: Q3 2025 76.3k, Q4 2025 73.1k, Q1 2026 64.5k, Q2 2026 58.4k -6.1k -6,100 -9.5%
49 ELEVANCE HEALTH INC COM ELV ELV 56,449 $21.8m0.46% 0.46% AddedShares held: Q3 2025 105.0k, Q4 2025 69.6k, Q1 2026 52.5k, Q2 2026 56.4k +3.9k +3,931 7.5%
50 TANGO THERAPEUTICS INC COM TNGX TNGX 694,182 $21.7m0.46% 0.46% ReducedShares held: Q3 2025 0, Q4 2025 3.9m, Q1 2026 2.4m, Q2 2026 694.2k -1.7m -1,705,818 -71.1%
51 STERIS PLC SHS USD STE STE 99,877 $21.0m0.44% 0.44% ReducedShares held: Q3 2025 118.1k, Q4 2025 101.7k, Q1 2026 99.9k, Q2 2026 99.9k -1 -1 0.0%
52 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 229,931 $20.4m0.43% 0.43% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 229.9k
53 HEMAB THERAPEUTICS HLDGS INC COM SHS COAG COAG 550,000 $20.2m0.43% 0.43% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 550.0k
54 INSULET CORP COM PODD PODD 127,498 $19.4m0.41% 0.41% ReducedShares held: Q3 2025 212.0k, Q4 2025 186.7k, Q1 2026 163.7k, Q2 2026 127.5k -36.2k -36,158 -22.1%
55 THE CIGNA GROUP COM CI CI 66,500 $18.3m0.39% 0.39% ReducedShares held: Q3 2025 122.5k, Q4 2025 110.0k, Q1 2026 98.3k, Q2 2026 66.5k -31.8k -31,763 -32.3%
56 GLAUKOS CORP COM GKOS GKOS 128,667 $18.0m0.38% 0.38% ReducedShares held: Q3 2025 55.9k, Q4 2025 261.9k, Q1 2026 145.7k, Q2 2026 128.7k -17.0k -17,036 -11.7%
57 CVS HEALTH CORP COM CVS CVS 169,366 $17.5m0.37% 0.37% AddedShares held: Q3 2025 51.2k, Q4 2025 109.1k, Q1 2026 89.4k, Q2 2026 169.4k +80.0k +80,003 89.5%
58 BECTON DICKINSON & CO COM BDX BDX 109,729 $16.6m0.35% 0.35% ReducedShares held: Q3 2025 296.9k, Q4 2025 265.7k, Q1 2026 121.9k, Q2 2026 109.7k -12.2k -12,158 -10.0%
59 GE HEALTHCARE TECHNOLOGIES I COMMON STOCK GEHC GEHC 252,744 $16.2m0.34% 0.34% ReducedShares held: Q3 2025 463.1k, Q4 2025 424.5k, Q1 2026 416.9k, Q2 2026 252.7k -164.1k -164,143 -39.4%
60 LIVANOVA PLC SHS LIVN LIVN 195,621 $16.1m0.34% 0.34% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 186.2k, Q2 2026 195.6k +9.4k +9,436 5.1%
61 CENTENE CORP DEL COM CNC CNC 228,865 $14.7m0.31% 0.31% ReducedShares held: Q3 2025 281.9k, Q4 2025 273.7k, Q1 2026 261.1k, Q2 2026 228.9k -32.2k -32,201 -12.3%
62 MERCK & CO INC COM MRK MRK 113,061 $14.5m0.31% 0.31% ReducedShares held: Q3 2025 34.7k, Q4 2025 92.1k, Q1 2026 206.6k, Q2 2026 113.1k -93.5k -93,530 -45.3%
63 COOPER COS INC COM COO COO 197,135 $14.1m0.30% 0.30% ReducedShares held: Q3 2025 292.3k, Q4 2025 292.0k, Q1 2026 272.2k, Q2 2026 197.1k -75.0k -75,049 -27.6%
64 PARABILIS MEDICINES INC COM PBLS PBLS 500,000 $13.7m0.29% 0.29% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 500.0k
65 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 345,899 $11.7m0.25% 0.25% AddedShares held: Q3 2025 424.1k, Q4 2025 327.9k, Q1 2026 250.1k, Q2 2026 345.9k +95.8k +95,817 38.3%
66 GLOBUS MED INC CL A GMED GMED 146,108 $11.5m0.24% 0.24% ReducedShares held: Q3 2025 326.9k, Q4 2025 262.7k, Q1 2026 247.3k, Q2 2026 146.1k -101.2k -101,153 -40.9%
67 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 502,286 $11.3m0.24% 0.24% UnchangedShares held: Q3 2025 463.4k, Q4 2025 515.4k, Q1 2026 502.3k, Q2 2026 502.3k
68 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 126,707 $10.9m0.23% 0.23% ReducedShares held: Q3 2025 245.2k, Q4 2025 238.7k, Q1 2026 155.6k, Q2 2026 126.7k -28.9k -28,864 -18.6%
69 VEEVA SYS INC CL A COM VEEV VEEV 59,347 $10.5m0.22% 0.22% AddedShares held: Q3 2025 97.5k, Q4 2025 80.5k, Q1 2026 56.5k, Q2 2026 59.3k +2.8k +2,830 5.0%
70 ABBVIE INC COM ABBV ABBV 40,476 $10.2m0.21% 0.21% ReducedShares held: Q3 2025 170.9k, Q4 2025 134.9k, Q1 2026 93.6k, Q2 2026 40.5k -53.1k -53,091 -56.7%
71 10X GENOMICS INC CL A COM TXG TXG 261,470 $10.0m0.21% 0.21% ReducedShares held: Q3 2025 313.8k, Q4 2025 322.1k, Q1 2026 329.5k, Q2 2026 261.5k -68.0k -68,022 -20.6%
72 HCA HEALTHCARE INC COM HCA HCA 23,750 $9.3m0.19% 0.19% ReducedShares held: Q3 2025 65.6k, Q4 2025 43.9k, Q1 2026 37.8k, Q2 2026 23.8k -14.0k -14,015 -37.1%
73 AURA BIOSCIENCES INC COM AURA AURA 1,166,667 $8.3m0.17% 0.17% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2m
74 MCKESSON CORP COM MCK MCK 9,625 $7.3m0.15% 0.15% ReducedShares held: Q3 2025 38.0k, Q4 2025 25.1k, Q1 2026 22.4k, Q2 2026 9.6k -12.7k -12,727 -56.9%
75 TENET HEALTHCARE CORP COM NEW THC THC 38,868 $7.3m0.15% 0.15% AddedShares held: Q3 2025 40.4k, Q4 2025 40.2k, Q1 2026 38.3k, Q2 2026 38.9k +599 +599 1.6%
76 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 55,682 $6.8m0.14% 0.14% AddedShares held: Q3 2025 20.6k, Q4 2025 16.5k, Q1 2026 14.4k, Q2 2026 55.7k +41.2k +41,235 285.4%
77 NATERA INC COM NTRA NTRA 24,806 $6.7m0.14% 0.14% ReducedShares held: Q3 2025 91.8k, Q4 2025 56.0k, Q1 2026 31.7k, Q2 2026 24.8k -6.9k -6,888 -21.7%
78 TRANSMEDICS GROUP INC COM TMDX TMDX 101,139 $6.7m0.14% 0.14% UnchangedShares held: Q3 2025 117.0k, Q4 2025 97.9k, Q1 2026 101.1k, Q2 2026 101.1k
79 MOLINA HEALTHCARE INC COM MOH MOH 27,761 $6.3m0.13% 0.13% NewShares held: Q3 2025 91.0k, Q4 2025 46.6k, Q1 2026 0, Q2 2026 27.8k
80 ALKERMES PLC SHS ALKS ALKS 120,243 $6.3m0.13% 0.13% AddedShares held: Q3 2025 6.6k, Q4 2025 6.6k, Q1 2026 8.9k, Q2 2026 120.2k +111.4k +111,373 1255.6%
81 ROYALTY PHARMA PLC SHS CLASS A RPRX RPRX 112,311 $6.3m0.13% 0.13% AddedShares held: Q3 2025 13.0k, Q4 2025 13.2k, Q1 2026 38.3k, Q2 2026 112.3k +74.0k +74,015 193.3%
82 WAYSTAR HLDG CORP COM WAY WAY 293,592 $6.0m0.13% 0.13% AddedShares held: Q3 2025 129.9k, Q4 2025 241.7k, Q1 2026 256.1k, Q2 2026 293.6k +37.5k +37,453 14.6%
83 PRIVIA HEALTH GROUP INC COM PRVA PRVA 226,703 $5.8m0.12% 0.12% UnchangedShares held: Q3 2025 666.2k, Q4 2025 448.2k, Q1 2026 226.7k, Q2 2026 226.7k
84 GMR SOLUTIONS INC COM CL A GMRS GMRS 333,333 $5.2m0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 333.3k
85 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 24,037 $4.1m0.09% 0.09% AddedShares held: Q3 2025 1.8m, Q4 2025 1.7m, Q1 2026 4.6k, Q2 2026 24.0k +19.4k +19,391 417.4%
86 OMADA HEALTH INC COM OMDA OMDA 157,938 $3.5m0.07% 0.07% UnchangedShares held: Q3 2025 251.8k, Q4 2025 177.9k, Q1 2026 157.9k, Q2 2026 157.9k
87 KESTRA MED TECHNOLOGIES LTD SHS KMTS KMTS 129,215 $3.3m0.07% 0.07% AddedShares held: Q3 2025 128.7k, Q4 2025 115.8k, Q1 2026 115.6k, Q2 2026 129.2k +13.6k +13,625 11.8%
88 MEDLINE INC COM CL A MDLN MDLN 82,153 $3.2m0.07% 0.07% ReducedShares held: Q3 2025 0, Q4 2025 117.7k, Q1 2026 136.6k, Q2 2026 82.2k -54.5k -54,482 -39.9%
89 ILLUMINA INC COM ILMN ILMN 18,134 $3.2m0.07% 0.07% ReducedShares held: Q3 2025 23.8k, Q4 2025 22.9k, Q1 2026 20.2k, Q2 2026 18.1k -2.1k -2,089 -10.3%
90 BEIGENE LTD SPONSORED ADR ONC ONC 10,474 $3.0m0.06% 0.06% AddedShares held: Q3 2025 33.8k, Q4 2025 1.9k, Q1 2026 3.8k, Q2 2026 10.5k +6.7k +6,662 174.8%
91 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 86,994 $2.9m0.06% 0.06% AddedShares held: Q3 2025 14.6k, Q4 2025 36.3k, Q1 2026 27.7k, Q2 2026 87.0k +59.3k +59,333 214.5%
92 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 4,675 $2.5m0.05% 0.05% AddedShares held: Q3 2025 2.4k, Q4 2025 2.9k, Q1 2026 3.0k, Q2 2026 4.7k +1.6k +1,635 53.8%
93 SPDR S&P 500 ETF TR TR UNIT SPY SPY 2,700 $2.0m0.04% 0.04% UnchangedShares held: Q3 2025 3.1k, Q4 2025 3.1k, Q1 2026 2.7k, Q2 2026 2.7k
94 BIONTECH SE SPONSORED ADS BNTX BNTX 21,229 $2.0m0.04% 0.04% AddedShares held: Q3 2025 34.0k, Q4 2025 43.8k, Q1 2026 20.9k, Q2 2026 21.2k +378 +378 1.8%
95 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 89,439 $1.9m0.04% 0.04% AddedShares held: Q3 2025 168.5k, Q4 2025 298.1k, Q1 2026 76.2k, Q2 2026 89.4k +13.3k +13,258 17.4%
96 CYTOKINETICS INC COM NEW CYTK CYTK 19,007 $1.6m0.03% 0.03% AddedShares held: Q3 2025 2.1k, Q4 2025 9.2k, Q1 2026 8.8k, Q2 2026 19.0k +10.2k +10,166 115.0%
97 ALAMAR BIOSCIENCES INC COMMON STOCK ALMR ALMR 55,738 $1.5m0.03% 0.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 55.7k
98 PHREESIA INC COM PHR PHR 140,495 $1.4m0.03% 0.03% AddedShares held: Q3 2025 313.1k, Q4 2025 183.2k, Q1 2026 131.0k, Q2 2026 140.5k +9.5k +9,503 7.2%
99 MOBIA MED INC COMMON STOCK MOBI MOBI 100,000 $1.3m0.03% 0.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k
100 BILLIONTOONE INC CL A BLLN BLLN 10,554 $1.3m0.03% 0.03% UnchangedShares held: Q3 2025 0, Q4 2025 10.6k, Q1 2026 10.6k, Q2 2026 10.6k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
EDGEWISE THERAPEUTICS INC EWTX EWTX 1,528,518 $48.1m1.5m shares
INSPIRE MED SYS INC INSP INSP 99,735 $5.1m99.7k shares
PENUMBRA INC PEN PEN 12,267 $4.0m12.3k shares
ATRIUM THERAPEUTICS INC RNA RNA 263,096 $3.5m263.1k shares
MASIMO CORP MASI MASI 8,753 $1.6m8.8k shares
EQUINOR ASA EQNR EQNR 17,573 $741.6k17.6k shares
EXXON MOBIL CORP XOM XOM 4,370 $741.4k4.4k shares
BP PLC BP BP 15,644 $735.3k15.6k shares
SHELL PLC SHEL SHEL 7,844 $729.5k7.8k shares
CISCO SYS INC CSCO CSCO 8,000 $620.7k8.0k shares
ALIBABA GROUP HLDG LTD BABA BABA 4,700 $589.7k4.7k shares
PROCTER AND GAMBLE CO PG PG 3,900 $563.3k3.9k shares
MASTERCARD INCORPORATED MA MA 1,100 $549.6k1.1k shares
BLACKROCK INC BLK BLK 450 $432.8k450 shares
VISA INC V V 1,400 $423.1k1.4k shares
CENTESSA PHARMACEUTICALS PLC 9,030 $358.7k9.0k shares
JD.COM INC JD JD 11,000 $325.3k11.0k shares
ACCENTURE PLC IRELAND ACN ACN 1,500 $297.4k1.5k shares
ADOBE INC ADBE ADBE 1,200 $291.7k1.2k shares
OLEMA PHARMACEUTICALS INC OLMA OLMA 16,443 $245.2k16.4k shares
ASCENDIS PHARMA A/S 536 $122.6k536 shares
BRIDGEBIO ONCOLOGY THERAPEUT BBOT BBOT 6,982 $62.5k7.0k shares
WAVE LIFE SCIENCES LTD 96663EUR 96663EUR 5,261 $38.1k5.3k shares
QIAGEN NV QGEN QGEN 243 $9.7k243 shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-05-15 VRDN 6.6%≈ $123.6m new 13G 2026-05-15
IMMUNOCORE HLDGS PLC IMCR · 13G · filed 2025-11-14 IMCR 5.6% new 13G 2025-11-14
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-08-14 JBIO 5.0%≈ $67.9m -1.8 pts 13G 2026-08-14